Amylyx PharmaceuticalsAMLX
那斯達克 · USD
13.07
-0.16
(-1.21%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
Amylyx PharmaceuticalsAMLX
13.07
-0.16
(-1.21%)
財務數據
損益表
- 0.98
- 1.03
- 1.08
- 0.89
- -0.01
- 0.00
- -0.01
- -
- -
- -
- 37.50
- 4.56
- 5.61
- -18.26
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | -665 | 416 | -1,023 | 88,643 | 108,449 | 102,693 | 98,216 |
營業成本 | - | - | - | 0 | 809 | 7,418 | 116,406 | 9,360 | 5,218 | 5,580 |
營業毛利 | - | - | - | -665 | -393 | -8,441 | -27,763 | 99,089 | 97,475 | 92,636 |
營業費用 | 36,026 | 42,857 | - | 39,989 | - | 44,994 | 94,367 | 97,155 | 78,755 | 72,435 |
研發費用 | 19,855 | 27,217 | 22,119 | 22,892 | 21,237 | 23,347 | 36,608 | 44,914 | 30,037 | 29,044 |
推銷及管理費用 | 16,171 | 15,640 | 15,684 | 17,097 | 17,828 | 21,647 | 57,759 | 52,241 | 48,718 | 43,391 |
非經常性項目費用 | - | - | - | - | 36,203 | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -36,026 | -42,857 | -37,803 | -40,654 | -75,661 | -53,435 | -122,130 | 1,934 | 18,720 | 20,201 |
其他收入及費用 | 1,640 | 1,414 | 1,896 | - | 2,957 | - | 3,579 | 4,542 | 3,691 | 3,806 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -34,386 | -41,443 | -35,907 | -38,181 | -72,704 | -72,700 | -118,551 | 6,476 | 22,411 | 24,007 |
所得稅 | - | - | - | -635 | - | 0 | 242 | 1,745 | 1,518 | 1,933 |
稅後純益 | -34,386 | -41,443 | -35,907 | -37,546 | -72,704 | -72,700 | -118,793 | 4,731 | 20,893 | 22,074 |
基本每股稅後盈餘(元) | -0.37 | -0.46 | -0.42 | -0.55 | -1.07 | -1.07 | -1.75 | 0.07 | 0.31 | 0.33 |
稀釋每股稅後盈餘(元) | -0.37 | -0.46 | -0.42 | -0.55 | -1.07 | -1.07 | -1.75 | 0.07 | 0.29 | 0.32 |
基本平均股數(千股) | 93332.00 | 89138.00 | 85697.00 | 68593.00 | 68091.00 | 68024.00 | 67854.00 | 67414.00 | 67414.00 | 67233.00 |
稀釋平均股數(千股) | 93332.00 | 89138.00 | 85697.00 | 68593.00 | 68091.00 | 68024.00 | 67854.00 | 69196.00 | 69748.00 | 70132.00 |
還原基本每股稅後盈餘(元) | -0.37 | -0.46 | -0.42 | -0.55 | -1.07 | -1.07 | -1.75 | 0.07 | 0.31 | 0.33 |
還原稀釋每股稅後盈餘(元) | -0.37 | -0.46 | -0.42 | -0.55 | -1.07 | -1.07 | -1.75 | 0.07 | 0.29 | 0.32 |
還原基本平均股數(千股) | 93,332 | 89,138 | 85,697 | 68,593 | 68,091 | 68,024 | 67,854 | 67,414 | 67,414 | 67,233 |
還原稀釋平均股數(千股) | 93,332 | 89,138 | 85,697 | 68,593 | 68,091 | 68,024 | 67,854 | 69,196 | 69,748 | 70,132 |
EBITDA(千元) | -35,509 | -42,825 | -37,454 | -38,021 | -74,788 | -72,492 | -120,818 | 4,205 | 20,231 | 22,305 |